Clinical features of abnormal α-fetoprotein in 15 patients with chronic viral hepatitis B after treatment with antiviral drugs

Table 2 Pathological features of 15 patients with chronic hepatitis B combined with elevated alpha fetoprotein

No.	II	Lym/PCs I	FN	BN	FDL	LI	PI	BDI	ABD	Fibrosis	Ishak score	G	S
1	3	Yes	2	0	1	4	3	0	0	3	12	G3	S1
2	3	Yes	6	1	1	2	3	0	0	6	15	G3-4	S4
3	4	Yes	5	1	1	2	3	0	0	6	15	G3-4	S4
4	4	Yes	5	1	1	3	4	0	0	5	17	G3-4	S3-4
5	4	Yes	5	1	1	3	3	0	0	5	16	G2-3	S4
6	4	Yes	5	1	1	4	4	0	0	5	18	G4	S3-4
7	4	No	4	1	1	2	4	0	0	6	15	G2-3	S4
8	4	Yes	6	1	1	3	3	0	0	6	17	G4	S4
9	4	Yes	4	1	1	3	3	1	0	6	15	G3-4	S4
10	3	Yes	4	1	1	4	3	1	0	3	15	G3-4	S3-4
11	3	Yes	6	1	1	3	4	1	0	6	17	G3	S4
12	4	Yes	4	1	1	3	4	1	0	6	16	G4	S4
13	4	Yes	5	1	1	3	4	0	0	6	17	G3	S3-4
14	3	Yes	1	0	1	2	2	0	0	3	8	G3	S3-4
15	2	Yes	0	0	0	1	2	0	0	3	5	G2	S3-4

II: Interfacial inflammation; Lym/PCs I: Infiltration of lymphoid/plasma cells; FN: Fusion necrosis; BN: Bridging necrosis; FDL: Florid duct lesion; LI: Lobular inflammation; PI: Portal inflammation; BDI: Bile ductal injure; ABD: Absence of bile duct.